sglt2 inhibitors and glp 1 receptor agonists SGLT-2 GLP-1 in metabolic dysfunction-associated fatty liver disease GLP-1 Agonists vs. SGLT2 Inhibitors:

This indicates marked differences in the effects of GLP-1 on bone metabolism between different mammalian species [56, 58]

doi: 10.1017/neu.2016.69 119 LiX.JopeR

PubMed Systematic reviewGLP-1 class evidence2025 Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons

Lilly Launches Trulicity in the US First Ever Ready-to-Use Once-Weekly GLP-1 Receptor Agonist Eli Lilly launches Trulicity in the US first ready-to-use once-weekly GLP-1, available with a savings program for commercially insured patients

An exploratory study with sitagliptin and the GLP-1 receptor agonist liraglutide did not show additive effects, and whether there may be additional effects using shorter acting GLP-1 receptor agonists and DPP-4 inhibitors has not been studied yet (7072, 86)